Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement
Adam J. Lamble(Seattle Children's Hospital), Nirali N. Shah(National Institutes of Health), André Baruchel(Université Paris Cité), Constance M. Yuan(National Cancer Institute), Kevin O. McNerney(Children's Hospital of Philadelphia), Priya Kumar(Urology Team), Aimee C. Talleur(St. Jude Children's Research Hospital), Rebecca Thomas(Great Ormond Street Hospital), Sandra D. Bohling(Seattle Children's Hospital), Liora M. Schultz(Stanford Medicine), Sara Ghorashian(Great Ormond Street Hospital), Rebecca Gardner(Seattle Children's Hospital), Elad Jacoby(Edmond and Lily Safra Children's Hospital), Hao‐Wei Wang(Fu Jen Catholic University), Michael A. Pulsipher(Primary Children's Hospital), Swati Naik(St. Jude Children's Research Hospital), Kara L. Davis(Stanford Medicine)
Cited by 6
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744